Back

Five-year outcomes after pulmonary vein isolation versus atrioventricular nodal ablation with pacing in patients ≥75 years with persistent atrial fibrillation: a propensity-matched analysis

31 August 2026 (08:25 - 08:35)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation in the modern era: from technology to results Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Vishwesh Bharadiya

Mayo Clinic Hospital-Rochester, Rochester (United States of America)

3 More presentations in this session

Presentation thumbnail
Silent cerebral infarctions following pulsed-field ablation using FARAPULSE and PulseSelect
Doctor J. Onuma (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Outcomes and procedural characteristics of repeat ablation after vein of Marshall alcohol infusion combined with an anatomical ablation setup
Doctor F. Buoncristiani (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Reversible posterior wall electroporation following pentaspline versus balloon-in-basket pulsed-field ablation
Doctor I. Lopez Alacid (Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation in the modern era: from technology to results
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:25 CET
You may be interested in
thumbnail
Congress Presentation
Ablate versus Pace in Elderly Patients With Persistent Atrial Fibrillation
31 August 2026
thumbnail
Congress Presentation
Atrioventricular nodal ablation with pacemaker implant is associated with improved safety outcomes compared to pulmonary vein isolation of atrial fibrillation with heart failure
29 August 2022
thumbnail
Congress Session
Great Debates: catheter ablation for persistent atrial fibrillation - is it better than medication and is pulmonary vein isolation sufficient?
31 August 2024
thumbnail
Congress Presentation
Incidence of systolic heart failure and need for implantable cardiac defibrillators in patients with atrial fibrillation who had catheter ablation versus antiarrhythmic medical therapy
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources